{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:05:06Z","timestamp":1747181106371,"version":"3.40.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,30]]},"abstract":"<jats:p>To improve the curative effect of anti-hepatitis B virus (HBV) drugs, methods such as thymosin and entecavir combination have become a focus of clinical investigation. The aim of this retrospective experimental study was to explore the potential mechanism of action of thymosin a1 (Ta1) combined with entecavir in the treatment of HBV infection. A total of 28 patients with chronic hepatitis B, 29 patients treated with thymosin a1 and entecavir combination, and 15 healthy individuals were enrolled in this study. RT-qPCR was conducted to evaluate the mRNA levels of <jats:italic toggle=\"yes\">TLR9<\/jats:italic> in peripheral blood mononuclear cells (PBMCs). The serum level of TLR9 protein was analyzed by ELISA. The binding of <jats:italic toggle=\"yes\">TLR9<\/jats:italic> gene to the protein H3K9Ac in PBMCs was assessed by chromatin immunoprecipitation, and serum inflammatory factors were detected by Luminex technology. The expression levels of <jats:italic toggle=\"yes\">TLR9<\/jats:italic> mRNA and serum <jats:italic toggle=\"yes\">TLR9<\/jats:italic> protein in patients with HBV infection were significantly lower than those in subjects in the control group before treatment but increased after treatment with the Ta1 and entecavir combination. Moreover, the acetylation protein H3K9Ac was significantly bound to the promoter region of the <jats:italic toggle=\"yes\">TLR9<\/jats:italic> gene in patients with HBV infection treated with the Ta1 and entecavir combination compared to that in patients with HBV infection without treatment. Furthermore, the expression levels of interleukin 6 (IL-6), interleukin 12 (IL-12), interferon gamma, and necrosis factor alpha in patients with HBV infection after the combination treatment were slightly decreased compared to those in patients with HBV infection without treatment. In conclusion, the histone acetylation modification of <jats:italic toggle=\"yes\">TLR9<\/jats:italic> was significantly improved in patients with HBV infection after treatment with the Ta1 and entecavir combination, which elevated the expression of <jats:italic toggle=\"yes\">TLR9<\/jats:italic> at the mRNA and protein levels and further regulated the expression of IL-6, IL-12, and other cytokines.<\/jats:p>","DOI":"10.1097\/md.0000000000032431","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T13:06:18Z","timestamp":1672405578000},"page":"e32431","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["H3K9 acetylation modification and TLR9 immune regulation mechanism in patients after anti-HBV treatment"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9269-0074","authenticated-orcid":false,"given":"Haipeng","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, the Dongguan People\u2019s Hospital, Dongguan, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, P.R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Dongguan People\u2019s Hospital, Dongguan, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhuan","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Dongguan People\u2019s Hospital, Dongguan, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyang","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Dongguan People\u2019s Hospital, Dongguan, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sichun","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Dongguan People\u2019s Hospital, Dongguan, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbo","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Dongguan People\u2019s Hospital, Dongguan, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Dongguan People\u2019s Hospital, Dongguan, Guangdong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China.","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CM9.0000000000000067","article-title":"Alcohol consumption analysis among patients with liver disease in China.","volume":"132","author":"Xie","year":"2019","journal-title":"Chin Med J"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14218\/JCTH.2019.00040","article-title":"Liver stiffness measurement can reflect the active liver necroinflammation in population with chronicliver disease: a real-world evidence study.","volume":"7","author":"Wang","year":"2019","journal-title":"J Clin Transl Hepatol"},{"key":"R4-20250504","first-page":"4541","article-title":"Predictive value of plasmacytoid dendritic cells and Toll-like receptor-9 regarding the treatment efficacy of interferon-\u03b1 in HBeAg-positive chronic hepatitis B patients.","volume":"18","author":"Chen","year":"2019","journal-title":"Exp Ther Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"104748","DOI":"10.1016\/j.antiviral.2020.104748","article-title":"Adoptive T-cell therapy for HBV-associated HCC and HBV infection.","volume":"176","author":"Tan","year":"2020","journal-title":"Antiviral Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2018.04.017","article-title":"Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.","volume":"155","author":"Liu","year":"2018","journal-title":"Antiviral Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2019.09.025","article-title":"Tenofovir is associated with lower risk of hepatocellular carcinoma than entecavir in patients with chronic HBV infection in China.","volume":"158","author":"Terry","year":"2020","journal-title":"Gastroenterology"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"s318","DOI":"10.1016\/S0168-8278(13)60783-7","article-title":"781 a clinical trial on anti-HBV-DC vaccine combined with lamivudine and thymosin-a1 in the HBeAg positive patients of chronic hepatitis B virus infection.","volume":"58","author":"Wu","year":"2013","journal-title":"J Hepatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(01)80485-2","article-title":"A meta-analysis of thymosin-a1 treatment in chronic hepatitis B virus (HBV) infection.","volume":"34","author":"Chan","year":"2001","journal-title":"J Hepatol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"A380","DOI":"10.1016\/S0016-5085(01)81888-6","article-title":"Comparison of interteron \u03b12\u03b2 monotherapy with the combination of thymosin \u03b1\u03b11 and interferon \u03b12b in the treatment of anti-HBe-postive chronic hepatitis B in turkey.","volume":"120","author":"Saruc","year":"2001","journal-title":"Gastroenterology"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3748\/wjg.v7.i3.407","article-title":"Preliminary results of Thymosin-a1 versus interferon-\u03b1 treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B.","volume":"7","author":"Zhuang","year":"2001","journal-title":"World J Gastroenterol"},{"key":"R12-20250504","first-page":"395","article-title":"Aimmunochemical and physical-chemical evidence for the presence of thymosin alpha1-peptide in dialyzable leukocyte extracts1.","author":"Gregory","year":"1983","journal-title":"Immunobiol Transf Factor"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cld.2007.08.002","article-title":"Molecular virology of hepatitis B virus for clinicians.","volume":"11","author":"Block","year":"2007","journal-title":"Clin Liver Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2018.08.001","article-title":"Effect of a C-end rule modification on antitumor activity of thymosin \u03b11.","volume":"154","author":"Wang","year":"2018","journal-title":"Biochimie"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0083-6729(03)01007-0","article-title":"The thymosins: prothymosin \u03b1, parathymosin, and \u03b2-thymosins: structure and function.","volume":"66","author":"Hannappel","year":"2003","journal-title":"Vitam Horm"},{"key":"R16-20250504","first-page":"1044","article-title":"Toll-like receptors and the control of immunity.","volume":"180","author":"Katherine","year":"2010","journal-title":"Cell"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"104192","DOI":"10.1016\/j.phrs.2019.03.001","article-title":"Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists.","volume":"154","author":"Bourquin","year":"2020","journal-title":"Pharmacol Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.fsi.2019.02.038","article-title":"Diurnal rhythm and pathogens induced expression of toll-like receptor 9 (TLR9) in Pelteobagrus vachellii.","volume":"87","author":"Qin","year":"2019","journal-title":"Fish Shellfish Immunol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2006-02-004762","article-title":"Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.","volume":"108","author":"Romani","year":"2006","journal-title":"Blood"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","article-title":"TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6\u2013mediated pathways in IgA nephropathy.","volume":"97","author":"Makita","year":"2020","journal-title":"Kidney Int"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.archoralbio.2018.06.006","article-title":"Culture supernatants of oral cancer cells induce impaired IFN-\u03b1 production of pDCs partly through the down-regulation of TLR-9 expression.","volume":"93","author":"Han","year":"2018","journal-title":"Arch Oral Biol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/sji.12341","article-title":"Genomewide histone H3 lysine 9 acetylation profiling in CD4+ T cells revealed endoplasmic reticulum stress deficiency in patients with acute-on-chronic liver failure.","volume":"82","author":"Jin","year":"2015","journal-title":"Scand J Immunol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/postgradmedj-2013-132309","article-title":"TLR9: an important molecule in the fight against hepatitis B virus.","volume":"90","author":"Shahrakyvahed","year":"2014","journal-title":"Postgrad Med J"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.fsi.2014.11.002","article-title":"Humoral immune response and TLR9 gene expression in Pacific red snapper (Lutjanus peru) experimentally exposed to Aeromonas veronii.","volume":"42","author":"Martha","year":"2015","journal-title":"Fish Shellfish Immunol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.micinf.2009.02.008","article-title":"Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9.","volume":"11","author":"Xie","year":"2009","journal-title":"Microbes Infect"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.molimm.2009.04.031","article-title":"HBsAg inhibits TLR9-mediated activation and IFN-\u03b1 production in plasmacytoid dendritic cells.","volume":"46","author":"Xu","year":"2009","journal-title":"Mol Immunol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"S988","DOI":"10.1016\/S0016-5085(12)63832-3","article-title":"Mo1532 predictors of response to entecavir in chronic hepatitis B patients with incomplete virologic response to telbivudine in a four-year prospective cohort.","volume":"142","author":"Lo","year":"2012","journal-title":"Gastroenterology"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.theriogenology.2020.03.006","article-title":"Changes of histone H3 lysine 23 acetylation and methylation in porcine somatic cells, oocytes and preimplantation embryos.","volume":"148","author":"Lin","year":"2020","journal-title":"Theriogenology"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuroscience.2017.07.064","article-title":"Effect of melatonin on neuronal differentiation requires CBP\/p300-mediated acetylation of histone H3 lysine 14.","volume":"36419","author":"Li","year":"2017","journal-title":"Neuroscience"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2016.05.060","article-title":"Histone H3 acetylation in the postmortem Parkinson\u2019s disease primary motor cortex.","volume":"6273","author":"Gebremedhin","year":"2016","journal-title":"Neurosci Lett"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3892\/etm.2016.3271","article-title":"Depression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis.","volume":"12","author":"Zhu","year":"2016","journal-title":"Exp Ther Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.24434","article-title":"Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.","volume":"54","author":"Peng","year":"2011","journal-title":"Hepatology"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2019.08.024","article-title":"Wenting Tan1, TNF-\u03b1\/IFN-\u03b3 profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.","volume":"72","author":"Wang","year":"2020","journal-title":"J Hepatol"},{"key":"R34-20250504","first-page":"84","article-title":"The effect of entecavir therapy on immune status in chronic hepatitis B patients.","volume":"16","author":"Yan","year":"2019","journal-title":"Iran J Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:26:29Z","timestamp":1746332789000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":34,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032431","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}